Federal contractor · MOUNTAIN VIEW, CA
TAKARA BIO USA, INC.
TAKARA BIO USA, INC. received $40.5K in federal contract obligations in FY2026, on 4 awards (−17% vs FY2025). Since FY2017: $2.7M. Its largest customer was National Institutes of Health ($40.5K).
- Obligations · FY2026
- $40.5K
- New awards
- 4
- Sole-source
- 40%
- Single offer
- 61%
- UEI
- SCQNFFL3RJD9
- Parent company
- TAKARA HOLDINGS, INC.
Spending by fiscal year
Obligations per federal fiscal year (October–September).
- 255.2KFY2017
- 468KFY2018
- 730.8KFY2019
- 586.7KFY2020
- 159.2KFY2021
- 109.3KFY2022
- 84KFY2023
- 179.4KFY2024
- 48.6KFY2025
- 40.5KFY2026
Top buying agencies
Obligations in FY2026.
- National Institutes of Health$40.5K100%4 awards
What was bought · Where the work was performed
Obligations in FY2026.
What was bought
- Health & medical$40.6K100%
Where the work was performed
- Santa Clara County, CA$40.5K100%
Integrity signals
Shares of the year's obligations, next to the country's.
- Low competition100%US 39% · $40.6K
- Sole-source awards40%US 30% · $16K
- Single-offer competitions61%US 8.7% · $24.6K
- Urgency justifications0.0%US 5.1% · $0
A signal is a reason to look closer, not evidence of wrongdoing: most sole-source awards are lawful and justified.
Agencies awarding it sole-source contracts
- Department of Health and Human Services · 1 awards
Largest awards
- National Institutes of Health· Santa Clara County, CA· Health & medical· May 20, 2026 – May 20, 2026· 75N98026P00556
- National Institutes of Health· Santa Clara County, CA· Health & medical· Jun 11, 2026 – Jun 11, 2026· 75N98026P00754
- National Institutes of Health· Santa Clara County, CA· Other equipment & supplies· Aug 26, 2021 – Jul 20, 2026· 75N92B21P00064
- National Institutes of Health· Montgomery County, MD· Equipment maintenance· Apr 24, 2026 – Apr 27, 2026· 75N98026P00270
Competitors
Companies that win from the same buyers in the same markets: obligations by agency and industry compared over the last three fiscal years.
Compared on 3 markets (agency × industry), FY2024–FY2026.
- DNA TWOPOINTO INC.$225K0% in FY2026NEWARK, CA · 84% of this company's obligations are in markets they both serveNational Institutes of Health · Pharmaceutical and medicine manufacturing
- MEDUNIK USA INC$210KPRINCETON, NJ · 78% of this company's obligations are in markets they both serveNational Institutes of Health · Pharmaceutical and medicine manufacturing
- GEMINI BIOPRODUCTS LLC$204.2K−100% in FY2026WEST SACRAMENTO, CA · 3 entities · 76% of this company's obligations are in markets they both serveNational Institutes of Health · Pharmaceutical and medicine manufacturing
Showing the top 3 of 25 competitors. Open the profile for the full list.
Who sells to the same buyers in the same markets, not who wins against whom on a given contract. Prime contract obligations by the agency and NAICS code of each award; subawards are never added. A company is a family of legal entities, joined by parent UEI or, in part, by an AI reading of names.
Source: Federal contract transactions (Federal Procurement Data System) (U.S. Department of the Treasury, USAspending.gov), data current to Oct 9, 2026, loaded Oct 9, 2026 · FY2024–FY2026.
Source: Federal contract transactions (Federal Procurement Data System) (U.S. Department of the Treasury, USAspending.gov), data current to Oct 9, 2026, loaded Oct 9, 2026.